The effect of metformin on cardiovascular risk profile in patients without diabetes presenting with acute myocardial infarction: data from the Glycometabolic Intervention as adjunct to Primary Coronary Intervention in ST Elevation Myocardial Infarction (GIPS-III) trial

OBJECTIVE: In patients with diabetes mellitus, metformin treatment is associated with reduced mortality and attenuation of cardiovascular risk. As a subanalysis of the Glycometabolic Intervention as adjunct to Primary Coronary Intervention in ST Elevation Myocardial Infarction (GIPS-III) study, we e...

Descripción completa

Detalles Bibliográficos
Autores principales: Lexis, Chris P H, van der Horst-Schrivers, Anouk N A, Lipsic, Erik, Valente, Mattia A E, Muller Kobold, Anneke C, de Boer, Rudolf A, van Veldhuisen, Dirk J, van der Harst, Pim, van der Horst, Iwan C C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2015
Materias:
Cardiovascular and Metabolic Risk
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4679814/
https://www.ncbi.nlm.nih.gov/pubmed/26688733
http://dx.doi.org/10.1136/bmjdrc-2015-000090

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4679814/
https://www.ncbi.nlm.nih.gov/pubmed/26688733
http://dx.doi.org/10.1136/bmjdrc-2015-000090

Ejemplares similares